SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031877
Filing Date
2024-08-14
Accepted
2024-08-14 08:00:40
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 537409
2 ex31-1.htm EX-31.1 12744
3 ex31-2.htm EX-31.2 12791
4 ex31-3.htm EX-31.3 12751
5 ex32-1.htm EX-32.1 11192
6 form10-q_001.jpg GRAPHIC 91881
7 form10-q_002.jpg GRAPHIC 54124
  Complete submission text file 0001493152-24-031877.txt   3988002

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cocp-20240630.xsd EX-101.SCH 29486
9 XBRL CALCULATION FILE cocp-20240630_cal.xml EX-101.CAL 41201
10 XBRL DEFINITION FILE cocp-20240630_def.xml EX-101.DEF 111317
11 XBRL LABEL FILE cocp-20240630_lab.xml EX-101.LAB 307278
12 XBRL PRESENTATION FILE cocp-20240630_pre.xml EX-101.PRE 238418
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 381358
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 241204247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)